Among several putative risk factors involved in the development of PCa, such as mutations [233] in genes associated with DNA repair and androgen receptor (AR) activation [234,235,236], elevated chronic inflammation in the prostatic microenvironment is known to be correlated with cancer development [237,238]. The gene discussed is AR; the disease is posterior cortical atrophy.